Defeat Duchenne Canada launches 2023 Research Grant Program
Defeat Duchenne Canada (DDC) is the country’s largest charitable source of investment in cutting-edge Duchenne muscular dystrophy research. DDC have funded $16 million into the most promising international research focussed on improving outcomes for all individuals with this progressive disease.
DDC invites all investigators working on translational or clinical Duchenne research to apply to their 2023 Research Grant Program!
Funding Criteria
Read the full funding criteria to learn more about the grant program.
Upcoming Deadlines
The deadline to submit a letter of intent is April 21st, 2023.
Submit a letter of intent through the DDC web portal.
Read next...
Save the Date: 2027 NMD4C-RARE.Qc Basic Science Research Summer School
NMD4C and RARE.Qc are pleased to announce the 2027 NMD4C–RARE.Qc Basic Science Research Summer School, will take place May 12-14, 2027, at the Université du Québec à Trois-Rivières (UQTR). The Summer School will bring together graduate students, postdoctoral fellows, and early-career researchers for hands-on training workshops, scientific lectures, trainee presentations, networking opportunities, and engagement with leading experts in neuromuscular and rare disease research.
Now Open: 2027 Postdoctoral Research Fellowship Funding Competition
Deadline: Oct 14 2026 | We are happy to announce that applications for the 2027 Postdoctoral Research Fellowship Funding Competition, in partnership with Muscular Dystrophy Canada, is now open. This annual funding competition awards salary support to early-career scientists in interested in advancing their postdoctoral studies in neuromuscular disease (NMD) research.
Congratulations to our 2026 Collaborative Research Training Award Recipients!!!
We are excited to announce the recipients of the 2026 NMD4C Collaborative Research Training Awards, which supports Canadian trainees in their efforts to advance neuromuscular disease research while strengthening national collaboration among neuromuscular research laboratories.